Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
22.57
+0.18 (0.80%)
At close: Aug 15, 2025, 4:00 PM
22.57
0.00 (0.00%)
After-hours: Aug 15, 2025, 4:00 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $578.50 million as of August 15, 2025. Its market cap has increased by 33.63% in one year.
Market Cap
578.50M
Enterprise Value
315.01M
1-Year Change
33.63%
Ranking
Category
Stock Price
$22.57
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $578.50M, an increase of 160.97%. That is a compound annual growth rate of 69.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 579.79M | 11.49% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
| Oct 20, 2023 | 221.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 609.96B |
| Johnson & Johnson | 421.34B |
| AbbVie | 361.93B |
| UnitedHealth Group | 245.54B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.25B |